The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Maxx Pharma Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
33 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABEVMY bevacizumab 100 mg/4 mL concentrate injection for solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe.
-
Prescription medicine decision summaryTGA Decision: Vaxelis (DTPa5-HB-IPV-Hib) is approved as a vaccine for diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Hib.
-
Prescription medicine registrationActive ingredients: DTPa5-HB-IPV-Hib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ETERA etanercept 50 mg in 1.0 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ETERA etanercept 25 mg in 0.5 mL solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONGENTYS opicapone 50 mg hard capsule blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Eslicarbazepine acetate